文献速递瓣膜病与结构性心脏病

人工智能在超声心动图评估瓣膜性心脏病中的应用

Artificial intelligence for the echocardiographic assessment of valvular heart disease.
PubMed 文献 · Heart · 2022-09-26

本文综述了人工智能在瓣膜性心脏病超声心动图评估中的应用进展。AI可辅助图像采集、视图识别和瓣膜结构分割,并通过图像识别算法直接检测主动脉瓣和二尖瓣疾病状态。超声测量数据与临床数据整合有助于识别新的主动脉瓣疾病亚组和进展预测因子,未来有望实现精准医疗管理。

要点

  • AI可辅助超声图像采集、视图识别及瓣膜与心脏结构分割以实现自动化分析。
  • 图像识别算法可直接从超声图像中检测主动脉瓣和二尖瓣疾病状态。
  • 超声瓣膜评估测量值与临床数据整合可识别新的主动脉瓣疾病亚组及进展预测因子。

核心结论

  • 人工智能在瓣膜性心脏病的超声心动图评估中具有重要应用潜力,可辅助图像采集、视图识别、结构分割和疾病检测,并有望整合多源数据实现精准医疗管理。

研究设计与样本

  • 本文为综述,聚焦人工智能在瓣膜性心脏病超声心动图评估中的应用,未报告具体检索范围或纳入研究数量。

主要发现

  • AI可辅助图像采集、视图识别以及瓣膜和心脏结构的分割,以实现自动化分析。
  • 利用图像识别算法,可直接从超声图像中检测主动脉瓣和二尖瓣疾病状态。
  • 超声瓣膜评估中获得的测量值已与其他临床数据整合,用于识别新的主动脉瓣疾病亚组并描述主动脉瓣疾病进展的新预测因子。

临床怎么用

  • AI可辅助超声心动图图像采集和视图识别,提高瓣膜评估的效率和标准化。
  • AI可自动分割瓣膜和心脏结构,并直接检测主动脉瓣和二尖瓣疾病状态。
  • 超声测量值与临床数据整合可用于识别主动脉瓣疾病新亚组和进展预测因子,辅助风险分层。
  • 未来AI有望整合超声参数与其他临床数据,支持瓣膜性心脏病患者的精准医疗管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Developments in artificial intelligence (AI) have led to an explosion of studies exploring its application to cardiovascular medicine. Due to the need for training and expertise, one area where AI could be impactful would be in the diagnosis and management of valvular heart disease. This is because AI can be applied to the multitude of data generated from clinical assessments, imaging and biochemical testing during the care of the patient. In the area of valvular heart disease, the focus of AI has been on the echocardiographic assessment and phenotyping of patient populations to identify high-risk groups. AI can assist image acquisition, view identification for review, and segmentation of valve and cardiac structures for automated analysis. Using image recognition algorithms, aortic and mitral valve disease states have been directly detected from the images themselves. Measurements obtained during echocardiographic valvular assessment have been integrated with other clinical data to identify novel aortic valve disease subgroups and describe new predictors of aortic valve disease progression. In the future, AI could integrate echocardiographic parameters with other clinical data for precision medical management of patients with valvular heart disease.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Nedadur R, Wang B, Tsang W, et al. Artificial intelligence for the echocardiographic assessment of valvular heart disease. Heart. 2022. PMID: 35144983. doi:10.1136/heartjnl-2021-319725

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。